FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to a vitamin D derivative of formula (1), a pharmaceutical composition, a remyelination stimulator, a therapeutic agent based thereon.
EFFECT: obtaining novel derivatives of vitamin D, having excellent migration into the central nervous system, which stimulate differentiation of oligodendrocyte precursor cells or nerve stem cells into oligodendrocytes and thereby stimulate myelin sheath regeneration.
22 cl, 11 tbl, 359 ex
Title | Year | Author | Number |
---|---|---|---|
SHIP1 MODULATORS AND METHODS RELATED THERETO | 2014 |
|
RU2679805C2 |
NOVEL ACTIVATORS OF VITAMIN D RECEPTORS AND METHODS OF OBTAINING THEREOF | 2008 |
|
RU2535448C2 |
RMT5 INHIBITORS | 2019 |
|
RU2814198C2 |
AMIDES OF CONDENSED PIPERIDINE AS MODULATORS OF ION CHANNELS | 2014 |
|
RU2741810C2 |
C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | 2017 |
|
RU2716502C2 |
SELECTIVE GLYCOSIDASE INHIBITORS AND USE THEREOF | 2011 |
|
RU2609210C2 |
TRITERPENE DERIVATIVES OF LUPEOL TYPE AS ANTIVIRAL PREPARATIONS | 2010 |
|
RU2561604C2 |
PERMEABLE GLYCOSIDASE INHIBITORS AND USE THEREOF | 2013 |
|
RU2707292C2 |
NEW DERIVATIVE OF 3-AZABICYCLO[3.1.0]HEXANE AND USE THEREOF FOR MEDICAL PURPOSES | 2014 |
|
RU2701861C1 |
SELECTIVE GLYCOSIDASE INHIBITORS AND USE THEREOF | 2011 |
|
RU2592285C2 |
Authors
Dates
2024-05-20—Published
2021-09-14—Filed